Left Ventricular Echocardiographic Variables in Occupational Exposure to Lead

Document Type : Original Article (s)

Authors

1 Associate Professor, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

2 Cardiologist, Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Associate Professor, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

4 PhD Candidate, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

5 Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Lead contamination affects various body organs such as heart. This study was designed to assess the effects of lead on cardiac function in terms of echocardiographic indices among battery factory workers who are in constant exposure to lead.Methods: In a cross-sectional study, 142 male battery factory workers who had been exposed to lead for at least 1 year were evaluated. The subjects aged 25-55 years and were excluded if they had hypertension, diabetes, or cardiovascular diseases. Demographic characteristics, professional profile, lead exposure, history of respiratory diseases, drugs intake, height, weight and blood pressure and lifestyle information of the participants were recorded. Blood lead levels were measured through blood tests. M-mode and doppler echocardiography was finally performed over each subject. Linear regression analysis was used to analyze the data.Findings: The mean age of the subjects was 41.78 ± 13.58 years and the mean duration of lead exposure was 23.54 ± 14.44 years. The mean blood lead level was 7.59 ± 2.75 µg/dl. Left ventricular hypertrophy was detected in 12% of the participants. Blood lead levels were not significantly related with echocardiographic indices in the crude model or after adjustments for age alone or for age and other risk factors.Conclusion: Blood lead levels of our subjects were below standard values. Accordingly, no significant relation was found between left ventricular function indices and blood lead levels. However, lack of such relations could be caused by exclusion of individuals with hypertension or cardiovascular diseases. Structural modifications in battery factories following legislations in Iran might have been responsible for low blood lead levels among the subjects.

Keywords

References

  1. Jarup L. Hazards of heavy metal contamination. Br Med Bull 2003; 68: 167-82.
  2. Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect 2006; 114(10): 1538-41.
  3. Steenland K, Boffetta P. Lead and cancer in humans: where are we now? Am J Ind Med 2000; 38(3): 295-9.
  4. Agency for Toxic Substances and Disease Registry. Toxicological profile for lead [Online]. [cited 2007]; Available from: URL: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=96&tid=22.
  5. Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health 2009; 24(1): 15-45.
  6. Glenn BS, Stewart WF, Links JM, Todd AC, Schwartz BS. The longitudinal association of lead with blood pressure. Epidemiology 2003; 14(1): 30-6.
  7. Aiba Y, Ohshiba S, Horiguchi S, Morioka I, Miyashita K, Kiyota I, et al. Peripheral hemodynamics evaluated by acceleration plethysmography in workers exposed to lead. Ind Health 1999; 37(1): 3-8.
  8. Fenga C, Cacciola A, Martino LB, Calderaro SR, Di NC, Verzera A, et al. Relationship of blood lead levels to blood pressure in exhaust battery storage workers. Ind Health 2006; 44(2): 304-9.
  9. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation 2006; 114(13): 1388-94.
  10. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 2004; 109(25): 3196-201.
  11. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med 2002; 162(21): 2443-9.
  12. Jain NB, Potula V, Schwartz J, Vokonas PS, Sparrow D, Wright RO, et al. Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: the VA Normative Aging Study. Environ Health Perspect 2007; 115(6): 871-5.
  13. Kaewboonchoo O, Morioka I, Saleekul S, Miyai N, Chaikittiporn C, Kawai T. Blood lead level and cardiovascular risk factors among bus drivers in Bangkok, Thailand. Ind Health 2010; 48(1): 61-5.
  14. Pinto FJ. Echocardiography in left ventricular dysfunction. Ital Heart J 2004; 5(Suppl 6): 41S-7S.
  15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18(12): 1440-63.
  16. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59(9): 956-60.
  17. Poerner TC, Goebel B, Kralev S, Kaden JJ, Suselbeck T, Haase KK, et al. Impact of mitral E/A ratio on the accuracy of different echocardiographic indices to estimate left ventricular end-diastolic pressure. Ultrasound Med Biol 2007; 33(5): 699-707.
  18. Foppa M, Duncan BB, Rohde LE. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovasc Ultrasound 2005; 3: 17.
  19. Tepper A, Mueller C, Singal M, Sagar K. Blood pressure, left ventricular mass, and lead exposure in battery manufacturing workers. Am J Ind Med 2001; 40(1): 63-72.
  20. Zou HJ, Ding Y, Huang KL, Xu ML, Tang GF, Wu MH, et al. Effects of lead on systolic and diastolic cardiac functions. Biomed Environ Sci 1995; 8(4): 281-8.
  21. Schwartz J. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect 1991; 91: 71-5.
  22. Kasperczyk S, Przywara-Chowaniec B, Kasperczyk A, Rykaczewska-Czerwinska M, Wodniecki J, Birkner E, et al. Function of heart muscle in people chronically exposed to lead. Ann Agric Environ Med 2005; 12(2): 207-10.
  23. Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens 2011; 2011: 495349.
  24. Schafer S, Kelm M, Mingers S, Strauer BE. Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens 2002; 20(7): 1431-7.
  25. Cuspidi C, Negri F, Sala C, Mancia G. Masked hypertension and echocardiographic left ventricular hypertrophy: an updated overview. Blood Press Monit 2012; 17(1): 8-13.
  26. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect 2007; 115(3): 472-82.
  27. Vaziri ND. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol 2008; 295(2): H454-H465.
  28. Peters JL, Kubzansky LD, Ikeda A, Fang SC, Sparrow D, Weisskopf MG, et al. Lead concentrations in relation to multiple biomarkers of cardiovascular disease: the Normative Aging Study. Environ Health Perspect 2012; 120(3): 361-6.
  29. Vaziri ND, Gonick HC. Cardiovascular effects of lead exposure. Indian J Med Res 2008; 128(4): 426-35.
Journal of Isfahan Medical School
Volume 32, Issue 297 - Serial Number 297
July and August 2014
Pages 1269-1277

Files

History

  • Receive Date: 24 July 2014
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics